PLSM

MKT CAP:$23M

Pulsenmore Ltd. Ordinary Shares

Market Cap

$23M

Healthcare·Medical - Devices·🇮🇱 Israel·NASDAQ

Healthcare·Medical - Devices·🇮🇱·NASDAQ

Stock Price

$3.83-$3.53 (-47.96%)

Apr 22, 2026

Company Details

Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the pati...

CEO

Elazar Sonnenschein

IPO Date

Jan 21, 2026

Website

www.pulsenmore.com

Key Metrics TTM

Revenue

$5M

+17.5% YoY

Net Income

-$27M

EPS (Diluted)

-$4.24

Free Cash Flow

-$21M

Revenue / Share

$0.75

Gross Margin

35.8%

Operating Margin

-513.9%

Net Margin

-553.8%

FCF Margin

-432.4%

P/S

4.8x

P/E

—

Earnings Reports

Q2 2025

Jun 29, 2025

$1M+2.7%EPS -$1.07

FY 2024

Dec 30, 2024

$3M+55.6%EPS -$1.57

Q4 2024

Dec 30, 2024

$1M+40.8%EPS -$0.91

Q2 2024

Jun 29, 2024

$1M+76.0%EPS -$0.67

FY 2023

Dec 30, 2023

$2M-44.5%EPS -$2.52

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 21	$128.6K	-$43.3K	-$3M
Q4 21	$373.0K	$167.3K	-$4M
Q2 22	$959.0K	$383.3K	-$5M
Q4 22	$2M	$1M	-$8M
Q2 23	$654.2K	$268.4K	-$8M
Q4 23	$1M	$331.6K	-$7M
Q2 24	$1M	$411.7K	-$5M
Q4 24	$1M	$554.7K	-$6M
Q2 25	$1M	$430.8K	-$6M

Valuation

Quarter	P/S	P/E
Q2 21	—	—
Q4 21	—	—
Q2 22	—	—
Q4 22	11.0x	—
Q2 23	9.6x	—
Q4 23	8.3x	—
Q2 24	8.0x	—
Q4 24	9.2x	—
Q2 25	8.2x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 21	-$2M	-$3M
Q4 21	-$6M	-$6M
Q2 22	$1M	$1M
Q4 22	-$8M	-$9M
Q2 23	-$4M	-$5M
Q4 23	-$7M	-$7M
Q2 24	-$5M	-$5M
Q4 24	-$4M	-$4M
Q2 25	-$4M	-$4M

Capital Expenditures

Quarter	CapEx
Q2 21	$82.9K
Q4 21	$162.5K
Q2 22	$207.1K
Q4 22	$1M
Q2 23	$1M
Q4 23	$16.0K
Q2 24	$45.2K
Q4 24	$92.8K
Q2 25	$28.7K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 23	+408.7%	+209.7%
Q4 23	+177.5%	+77.6%
Q2 24	+20.0%	+2.2%
Q4 24	-31.3%	-24.0%
Q2 25	+80.8%	-14.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 21	$0	0.0%
Q4 21	$0	0.0%
Q2 22	$0	0.0%
Q4 22	$0	0.0%
Q2 23	$0	0.0%
Q4 23	$0	0.0%
Q2 24	$0	0.0%
Q4 24	$0	0.0%
Q2 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q2 21	$2M	$1M
Q4 21	$2M	$3M
Q2 22	$3M	$3M
Q4 22	$5M	$3M
Q2 23	$5M	$3M
Q4 23	$4M	$4M
Q2 24	$3M	$3M
Q4 24	$3M	$4M
Q2 25	$2M	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 21	$54M	$0	$54M
Q4 21	$36M	$13M	$49M
Q2 22	$33M	$29M	$62M
Q4 22	$4M	$48M	$52M
Q2 23	$26M	$19M	$45M
Q4 23	$7M	$32M	$39M
Q2 24	$4M	$27M	$32M
Q4 24	$11M	$17M	$29M
Q2 25	$7M	$18M	$26M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 21	6M	—	—
Q4 21	6M	+1.0%	—
Q2 22	6M	-4.6%	—
Q4 22	6M	+13.1%	—
Q2 23	6M	+0.1%	+9.0%
Q4 23	6M	+0.1%	+8.1%
Q2 24	6M	+0.2%	+13.5%
Q4 24	6M	+0.2%	+0.5%
Q2 25	6M	+2.5%	+2.9%

Shares Outstanding